ARCHIVES

Pauling Contends His Applications Included Essentials

This article is from The Cancer Letter archive.

Vol. 05 No. 17 | April 27, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

June Panel Meeting Dropped

June 3, 1977

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

National Action Plan: Steering committee Votes No Confidence In HHS Official.

August 15, 1997

Diet Intervention Results Could Be Found In Months

April 4, 1986

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014